Morphic Holding Inc. (MORF)
NASDAQ: MORF
· Real-Time Price · USD
56.99
0.02 (0.04%)
At close: Aug 15, 2024, 10:00 PM
Morphic Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| Upfront Payment Revenue Revenue | 1.9M | 7.15M | 3.65M |
| Upfront Payment Revenue Revenue Growth | -73.42% | +95.70% | n/a |
| License Revenue | 57.7M | 10.31M | 8.6M |
| License Revenue Growth | +459.76% | +19.90% | n/a |
| Reimbursement Revenue Revenue | 51K | 10M | 10M |
| Reimbursement Revenue Revenue Growth | -99.49% | 0.00% | n/a |
| Upfront Payment Revenue, First Two Programs Revenue | 10M | 5M | 5M |
| Upfront Payment Revenue, First Two Programs Revenue Growth | +100.00% | 0.00% | n/a |
| Upfront Payment Revenue, Third Program Revenue | 5M | n/a | n/a |
| Upfront Payment Revenue, Third Program Revenue Growth | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 15.96M | 11.16M | 9.58M | 10.38M | 9.58M | 9.28M | 8.01M | 8.3M | 8.23M | 7.59M | 7.44M | 7.28M | 7.14M | 5.95M | 5.13M | 4.75M | 4.2M | 4.42M | 3.43M | 2.9M | 2.08M | 1.83M | 2.04M | 1.41M | 972K | 935K |
| Selling, General, and Administrative Revenue Growth | +42.99% | +16.54% | -7.75% | +8.36% | +3.30% | +15.76% | -3.48% | +0.84% | +8.47% | +1.97% | +2.31% | +1.92% | +19.92% | +16.11% | +7.91% | +13.25% | -5.15% | +29.10% | +18.22% | +39.53% | +13.37% | -10.37% | +45.48% | +44.55% | +3.96% | n/a |
| Research and Development Revenue | 49M | 42.16M | 39.85M | 34.36M | 35.72M | 30.45M | 24.7M | 25.25M | 25.65M | 26.46M | 23.66M | 20.97M | 24.55M | 18.61M | 18.75M | 16M | 19.92M | 18.96M | 16.82M | 12.63M | 13.91M | 10.37M | 7.29M | 5.77M | 5.29M | 4.28M |
| Research and Development Revenue Growth | +16.22% | +5.79% | +15.97% | -3.79% | +17.31% | +23.27% | -2.15% | -1.59% | -3.06% | +11.86% | +12.84% | -14.61% | +31.91% | -0.75% | +17.22% | -19.68% | +5.05% | +12.72% | +33.12% | -9.15% | +34.11% | +42.31% | +26.36% | +8.96% | +23.55% | n/a |